Search - tctmd.com

Displaying 61 - 80 of 108

Sort: Relevancy | Date

Presentation TCT 2016

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert W. Yeh

October 31, 2016

Presentation TCT 2016

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses

October 31, 2016

Presentation TCT 2016

Case #4: Patent but Diseased SVG Used as a Conduit for Salvaging the Native Circulation

Presenter: Barry D. Rutherford, Gerard T. Wilkins, Colm Hanratty

October 30, 2016

Presentation TCT 2016

Case #3: SVG Occlusion With Heavily Calcified Native Vessel CTO With Viable Myocardium

Presenter: Barry D. Rutherford, Gerard T. Wilkins, Masahisa Yamane

October 30, 2016

Presentation TCT 2016

Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF

Presenter: Barry D. Rutherford, Gerard T. Wilkins, James M. McCabe

October 30, 2016

Presentation TCT 2016

Case #1: LIMA-LAD Anastomotic Lesion With Heavily Calcified Native LAD Lesion

Presenter: Barry D. Rutherford, Gerard T. Wilkins, David E. Kandzari

October 30, 2016

Presentation ESC 2016

Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial

Presenter: Raban V. Jeger

August 31, 2016

Presentation TCT 2015

Use of Endoanchors to Prevent or Treat Gutter-Related Endoleaks After Use of Chimneys and Parallel Grafts

Presenter: Wilson Y. Szeto, Rodney White, Zvonimir Krajcer

October 15, 2015

Presentation TCT 2015

Will Successful Adoption of Fenestrated/Branched Grafts in Complex Anatomy Improve Overall Patient Outcomes by Decreasing Off-label Usage of Standard EVAR Devices?

Presenter: Clifford J. Buckley, Zvonimir Krajcer, Christopher J. Kwolek

October 15, 2015

Presentation TCT 2015

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

Presenter: Jeffrey W. Moses, Erick Schampaert, Giuseppe Tarantini

October 14, 2015

Presentation TCT 2015

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Presenter: Jeffrey W. Moses, Erick Schampaert, Dimitri Karmpaliotis

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Presenter: Jeffrey W. Moses, Erick Schampaert, Nabil Dib

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Presenter: Jeffrey W. Moses, Erick Schampaert, Gert Richardt

October 14, 2015

Presentation TCT 2015

Atheroablation: Current Technologies and Techniques

Presenter: Jeffrey W. Moses, Erick Schampaert, Mohamed Abdel-Wahab

October 14, 2015

Presentation TCT 2015

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Presenter: Jeffrey W. Moses, Erick Schampaert, Barry D. Rutherford

October 14, 2015

Presentation TCT 2015

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Presenter: Jeffrey W. Moses, Erick Schampaert

October 14, 2015

Presentation TCT 2015

Just How Effective Is Hypothermia in Cardiac Arrest?

Presenter: Tanveer Rab, Holger Thiele, Michel R. Le May

October 14, 2015

Presentation TCT 2015

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Presenter: Tanveer Rab, Holger Thiele

October 14, 2015

Presentation TCT 2015

Escalation Therapies and RV Dysfunction: New Opportunities

Presenter: Tanveer Rab, Holger Thiele, Navin K. Kapur

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Presenter: Tanveer Rab, Holger Thiele, Aly El Banayosy

October 14, 2015

Advertisement

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Case #4: Patent but Diseased SVG Used as a Conduit for Salvaging the Native Circulation

Case #3: SVG Occlusion With Heavily Calcified Native Vessel CTO With Viable Myocardium

Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF

Case #1: LIMA-LAD Anastomotic Lesion With Heavily Calcified Native LAD Lesion

Drug-Eluting vs Bare Metal Stents in Saphenous Vein Grafts: The Prospective Randomized BASKET-SAVAGE Trial

Use of Endoanchors to Prevent or Treat Gutter-Related Endoleaks After Use of Chimneys and Parallel Grafts

Will Successful Adoption of Fenestrated/Branched Grafts in Complex Anatomy Improve Overall Patient Outcomes by Decreasing Off-label Usage of Standard EVAR Devices?

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Atheroablation: Current Technologies and Techniques

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Just How Effective Is Hypothermia in Cardiac Arrest?

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Escalation Therapies and RV Dysfunction: New Opportunities

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content